Commit Lozenge ads
This article was originally published in The Tan Sheet
TV spots for OTC smoking cessation lozenge airing now on major networks, GSK says. Designed by Arnold McGrath Worldwide, ads feature different angles of a lone cigarette against a simple background. "This thing you carry with you everywhere, this thing you obsess about and face ridicule for, this thing you're not sure you'll ever be able to quit, may have just met its match," a voiceover states, before detailing recommended use of Commit. TV spots will be complemented by 1Web site, newspaper ads in publications such as USA Today. Commit nicotine polacrilex lozenge debuted late last month, features "time to first cigarette" dosage selection tool (2"The Tan Sheet" Nov. 4, 2002, p. 3)...
You may also be interested in...
GlaxoSmithKline's Phase IV obligations for its Commit nicotine polacrilex lozenge include a study of consumers who are contraindicated for use of the OTC smoking cessation drug due to underlying health conditions, FDA's Oct. 31 approval letter states
With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.